D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Pacira BioSciences
PCRX
$984M
| $7.03M | 0.01% |
240,439
+34,423
| +17% | +$1.06M |
|
1527
CALL
NRG Energy
NRG
$21.8B
| $7.01M | 0.01% |
103,600
+43,600
| +73% | +$2.45M |
|
1528
Theravance Biopharma
TBPH
$884M
| $7.01M | 0.01% |
781,585
-69,623
| -8% | -$645K |
|
1529
Ionis Pharmaceuticals
IONS
$7.39B
| $6.96M | 0.01% |
160,482
+41,324
| +35% | +$1.97M |
|
1530
CALL
Cloudflare
NET
$115B
| $6.95M | 0.01% |
71,800
-249,100
| -78% | -$22.6M |
|
1531
CALL
Newmont
NEM
$130B
| $6.93M | 0.01% |
193,400
+126,800
| +190% | +$4.37M |
|
1532
PUT
Tapestry
TPR
$22.9B
| $6.92M | 0.01% |
145,800
-69,300
| -32% | -$2.97M |
|
1533
Hancock Whitney
HWC
$6.01B
| $6.92M | 0.01% |
150,212
+90,877
| +153% | +$4.04M |
|
1534
XPO
XPO
$20.4B
| $6.92M | 0.01% |
56,670
-78,353
| -58% | -$8.39M |
|
|
NML
1535
Neuberger Energy Infrastructure and Income Fund Inc
NML
$598M
| $6.91M | 0.01% |
937,076
-201,075
| -18% | -$1.38M |
|
1536
CALL
Credit Acceptance
CACC
$6B
| $6.89M | 0.01% |
12,500
-10,300
| -45% | -$5.65M |
|
1537
PUT
Enbridge
ENB
$106B
| $6.87M | 0.01% |
190,000
-20,000
| -10% | -$710K |
|
1538
Mercury Systems
MRCY
$5.19B
| $6.86M | 0.01% |
232,640
+158,917
| +216% | +$4.79M |
|
1539
PUT
Penumbra
PEN
$12.5B
| $6.85M | 0.01% |
30,700
| – | – |
|
|
EB
1540
DELISTED
Eventbrite
EB
| $6.82M | 0.01% |
1,244,844
-535,899
| -30% | -$3.89M |
|
1541
Cannae Holdings
CNNE
$649M
| $6.82M | 0.01% |
306,468
+123,171
| +67% | +$2.6M |
|
1542
Tidewater
TDW
$4.31B
| $6.77M | 0.01% |
73,536
+34,496
| +88% | +$2.57M |
|
1543
Alpha Metallurgical Resources
AMR
$2.21B
| $6.76M | 0.01% |
20,423
+8,084
| +66% | +$2.96M |
|
1544
Inspire Medical Systems
INSP
$2.22B
| $6.76M | 0.01% |
31,488
-153,460
| -83% | -$30.1M |
|
1545
Pitney Bowes
PBI
$2.31B
| $6.75M | 0.01% |
1,558,754
-569,677
| -27% | -$2.35M |
|
1546
American States Water
AWR
$3.39B
| $6.75M | 0.01% |
93,400
+13,303
| +17% | +$992K |
|
1547
CALL
MetLife
MET
$61.7B
| $6.74M | 0.01% |
90,900
-290,000
| -76% | -$20.2M |
|
1548
LiveRamp
RAMP
$2.29B
| $6.73M | 0.01% |
195,204
-375,095
| -66% | -$13.8M |
|
|
P
1549
Everpure Inc
P
$34.7B
| $6.7M | 0.01% |
128,877
-91,592
| -42% | -$4.09M |
|
1550
Jones Lang LaSalle
JLL
$15.5B
| $6.69M | 0.01% |
34,307
+20,223
| +144% | +$3.68M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.